RESUMO
Glucocerebrosidase 1 (GBA1) mutations are the most important genetic risk factors for Parkinson's disease (PD). Clinically, mild (e.g., p.N370S) and severe (e.g., p.L444P and p.D409H) GBA1 mutations have different PD phenotypes, with differences in age at disease onset, progression, and the severity of motor and non-motor symptoms. We hypothesize that GBA1 mutations cause the accumulation of α-synuclein by affecting the cross-talk between cellular protein degradation mechanisms, leading to neurodegeneration. Accordingly, we tested whether mild and severe GBA1 mutations differentially affect the degradation of α-synuclein via the ubiquitin-proteasome system (UPS), chaperone-mediated autophagy (CMA), and macroautophagy and differentially cause accumulation and/or release of α-synuclein. Our results demonstrate that endoplasmic reticulum (ER) stress and total ubiquitination rates were significantly increased in cells with severe GBA1 mutations. CMA was found to be defective in induced pluripotent stem cell (iPSC)-derived dopaminergic neurons with mild GBA1 mutations, but not in those with severe GBA1 mutations. When examining macroautophagy, we observed reduced formation of autophagosomes in cells with the N370S and D409H GBA1 mutations and impairments in autophagosome-lysosome fusion in cells with the L444P GBA1 mutation. Accordingly, severe GBA1 mutations were found to trigger the accumulation and release of oligomeric α-synuclein in iPSC-derived dopaminergic neurons, primarily as a result of increased ER stress and defective macroautophagy, while mild GBA1 mutations affected CMA, which is mainly responsible for the degradation of the monomeric form of α-synuclein. Overall, our findings provide new insight into the molecular basis of the clinical variability in PD associated with different GBA1 mutations.
RESUMO
OBJECTIVES: to provide a revised version of earlier guidelines published in 2006. BACKGROUND: primary dystonias are chronic and often disabling conditions with a widespread spectrum mainly in young people. DIAGNOSIS: primary dystonias are classified as pure dystonia, dystonia plus or paroxysmal dystonia syndromes. Assessment should be performed using a validated rating scale for dystonia. Genetic testing may be performed after establishing the clinical diagnosis. DYT1 testing is recommended for patients with primary dystonia with limb onset before age 30, and in those with an affected relative with early-onset dystonia. DYT6 testing is recommended in early-onset or familial cases with cranio-cervical dystonia or after exclusion of DYT1. Individuals with early-onset myoclonus should be tested for mutations in the DYT11 gene. If direct sequencing of the DYT11 gene is negative, additional gene dosage is required to improve the proportion of mutations detected. A levodopa trial is warranted in every patient with early-onset primary dystonia without an alternative diagnosis. In patients with idiopathic dystonia, neurophysiological tests can help with describing the pathophysiological mechanisms underlying the disorder. TREATMENT: botulinum toxin (BoNT) type A is the first-line treatment for primary cranial (excluding oromandibular) or cervical dystonia; it is also effective on writing dystonia. BoNT/B is not inferior to BoNT/A in cervical dystonia. Pallidal deep brain stimulation (DBS) is considered a good option, particularly for primary generalized or cervical dystonia, after medication or BoNT have failed. DBS is less effective in secondary dystonia. This treatment requires a specialized expertise and a multidisciplinary team.
Assuntos
Toxinas Botulínicas/uso terapêutico , Estimulação Encefálica Profunda , Distonia/diagnóstico , Distonia/terapia , Distúrbios Distônicos/diagnóstico , Distúrbios Distônicos/terapia , Distonia/genética , Distonia/fisiopatologia , Distúrbios Distônicos/genética , Distúrbios Distônicos/fisiopatologia , Globo Pálido/fisiopatologia , Globo Pálido/cirurgia , Humanos , Chaperonas Moleculares/genéticaAssuntos
Encefalite , Receptores de N-Metil-D-Aspartato/imunologia , Seminoma/complicações , Seminoma/patologia , Teratoma/patologia , Neoplasias Testiculares/patologia , Adulto , Tonsila do Cerebelo/imunologia , Tonsila do Cerebelo/patologia , Anti-Inflamatórios/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Encefálicas/imunologia , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/terapia , Terapia Combinada , Encefalite/imunologia , Encefalite/patologia , Encefalite/terapia , Humanos , Imuno-Histoquímica , Masculino , Metilprednisolona/uso terapêutico , Síndromes Paraneoplásicas/patologia , Síndromes Paraneoplásicas/terapiaRESUMO
Hereditary spastic paraplegias (HSPs) are a heterogeneous group of neurodegenerative disorders leading to progressive spasticity of the lower limbs. Clinically, HSPs are divided into "pure" and "complicated" forms. In pure HSP, the spasticity of the lower limbs is the sole symptom, whereas in complicated forms additional neurological and non-neurological features are observed. Genetically, HSPs are divided into autosomal dominant (AD), autosomal recessive (AR) and X-linked (XL) forms. Up to date, 30 different HSPs are linked to different chromosomal loci and 11 genes could be defined for AR-HSP, AD-HSP and XL-HSP. SPG11, an AR-HSP (synonym: HSP11), is a complicated HSP associated with a slowly progressive spastic paraparesis, mental impairment and the development of a thin corpus callosum (TCC) during the course of the disease. SPG11 has been previously linked to chromosomal region 15q13 - 15. First, we applied rigid diagnostic criteria to systematically examine 20 Turkish families with autosomal recessive HSP for characteristic features of SPG11. We detected four large Turkish families with AR-HSP and TCC consistent with SPG11. Subsequent genetic linkage analysis of those 4 families refines the SPG11 locus further down to a small region of 2.93 cM with a maximum lod score of 11.84 at marker D15S659 and will guide further candidate gene analysis.
Assuntos
Corpo Caloso/patologia , Paraplegia Espástica Hereditária/genética , Paraplegia Espástica Hereditária/patologia , Adolescente , Adulto , Cromossomos Humanos Par 15/genética , Feminino , Genes Recessivos/genética , Ligação Genética , Genótipo , Humanos , Região de Controle de Locus Gênico/genética , Masculino , Linhagem , Paraplegia Espástica Hereditária/complicações , TurquiaRESUMO
The authors performed linkage analysis in 39 families with autosomal recessive early-onset PD (AR-EOPD) negative for parkin and DJ-1 mutations. Eight families including three Japanese, two Taiwanese, one Turkish, one Israeli, and one Philippine showed evidence of linkage with PARK6 with multipoint log of the odds (lod) score of 9.88 at D1S2732. The results indicate worldwide distribution of PARK6-linked parkinsonism.
Assuntos
Transtornos Cromossômicos/genética , Genes Recessivos/genética , Predisposição Genética para Doença/genética , Mutação/genética , Doença de Parkinson/genética , Proteínas Quinases/genética , Idade de Início , Ásia/epidemiologia , Transtornos Cromossômicos/etnologia , Transtornos Cromossômicos/metabolismo , Mapeamento Cromossômico , Análise Mutacional de DNA , Feminino , Frequência do Gene/genética , Ligação Genética/genética , Marcadores Genéticos/genética , Testes Genéticos , Haplótipos/genética , Humanos , Masculino , Repetições de Microssatélites/genética , Oriente Médio/epidemiologia , Doença de Parkinson/etnologia , Doença de Parkinson/metabolismo , LinhagemRESUMO
Nitric oxide can promote or inhibit apoptosis depending on the cell type and coexisting metabolic or experimental conditions. We examined the impact of nitric oxide on development of apoptosis 6, 24, and 72 h after permanent middle cerebral artery occlusion in mutant mice that lack the ability to generate nitric oxide from neuronal nitric oxide synthase. Adjacent coronal sections passing through the anterior commissure were stained with hematoxylin and eosin or terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). Immunoblotting was used to identify changes in the anti- and proapoptotic proteins Bcl-2 and Bax, respectively. Activation of caspases was assessed by appearance of actin cleavage products using a novel antiserum directed against 32-kDa actin fragment (fractin). In the neuronal nitric oxide synthase mutant mouse, infarct size and TUNEL positive apoptotic neurons were reduced compared to the wild-type controls. At 6 h, Bcl-2 levels in the ischemic hemisphere were increased in mutants but decreased in the wild-type strain. Bax levels did not change significantly. Caspase-mediated actin cleavage appeared in the ischemic hemisphere at this time point, and was significantly less in mutant brains at 72 h compared to the wild-type. The reduction in the number of TUNEL and fractin positive apoptotic cells appears far greater than anticipated based on the smaller lesion size in mutant mice.Hence, from these data we suggest that a deficiency in neuronal nitric oxide production slows the development of apoptotic cell death after ischemic injury and is associated with preserved Bcl-2 levels and delayed activation of effector caspases.
Assuntos
Apoptose/fisiologia , Isquemia Encefálica/enzimologia , Encéfalo/enzimologia , Neurônios/enzimologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico/fisiologia , Actinas/metabolismo , Animais , Encéfalo/patologia , Encéfalo/fisiopatologia , Isquemia Encefálica/patologia , Isquemia Encefálica/fisiopatologia , Caspases/metabolismo , Corantes/farmacologia , Fragmentação do DNA/fisiologia , Amarelo de Eosina-(YS)/farmacocinética , Feminino , Hematoxilina/farmacocinética , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Masculino , Camundongos , Camundongos Knockout , Neurônios/patologia , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína X Associada a bcl-2RESUMO
We report a case of Wilson's disease with circling seizures. Because of the existence of other types of frontal automatism and the EEG focus on the frontal regions, circling seizures of the patient were thought to originate from the frontal lobe. Magnetic resonance imaging demonstrated large cavitary lesions on bilateral frontal lobes. The mechanisms of circling behavior are discussed in association with Wilson's disease.
Assuntos
Eletroencefalografia , Epilepsia do Lobo Frontal/etiologia , Epilepsia do Lobo Frontal/fisiopatologia , Degeneração Hepatolenticular/complicações , Adolescente , Degeneração Hepatolenticular/fisiopatologia , Humanos , Imageamento por Ressonância Magnética , MasculinoRESUMO
Subacute sclerosing panencephalitis (SSPE) is associated with inflammatory infiltration, neuronal loss, and demyelination. The pathogenesis of these changes is unclear. We examined DNA fragmentation and Bcl-2 expression in brain biopsies of nineteen SSPE patients to investigate the role of apoptosis in tissue damage. DNA fragmentation was present in oligodendroglia, and, in tissues with neuronal loss, in neurons. Reactive astrocytes had no DNA fragmentation, but strong Bcl-2 expression. These results suggest apoptosis as one of the mechanisms for oligodendroglial and neuronal death in SSPE.
Assuntos
Apoptose , Encéfalo/patologia , Neurônios/patologia , Panencefalite Esclerosante Subaguda/patologia , Adolescente , Anticorpos Antivirais/imunologia , Apoptose/fisiologia , Biópsia , Criança , Pré-Escolar , Fragmentação do DNA/fisiologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Sarampo/complicações , Sarampo/imunologia , Neurônios/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Estudos Retrospectivos , Panencefalite Esclerosante Subaguda/metabolismo , Panencefalite Esclerosante Subaguda/virologiaRESUMO
OBJECTIVE: Exploring the (CAG)n expansion within IT 15 gene in Turkish Huntington's disease (HD) patients and its relation to downstream (CCG)n repeat polymorphism to elucidate population specific haplotypic heterogeneity. METHODS: Twenty-seven patients with clinical diagnosis of HD from 19 families were sampled. The triplet repeats were evaluated by sizing the fluorescent PCR products on an ABI 310 capillary gel electrophoresis unit. RESULTS: The number of (CAG)n repeat expansions (range: 40-76, mean: 45.6+/-7) were inversely correlated with age of onset (r=-0.81, P<0.0001). The (CCG)n polymorphism in HD chromosomes was confined to (CCG)7 in all patients. In normal chromosomes CAG polymorphism was accumulated at a relatively higher range (mean: 19.3+/-2.9) together with the common occurrence of(CCG)7 and (CCG)10 alleles. CONCLUSION: The distribution range of the CAG and CCG repeat polymorphism in normal chromosomes and strong linkage disequilibrium between HD mutation and (CCG)7 haplotype provided a striking similarity to populations of western European descent.
Assuntos
Doença de Huntington/genética , Polimorfismo Genético , Repetições de Trinucleotídeos , Adolescente , Adulto , Idade de Início , Alelos , Análise Mutacional de DNA , Europa (Continente) , Saúde da Família , Feminino , Haplótipos , Heterozigoto , Homozigoto , Humanos , Doença de Huntington/diagnóstico , Doença de Huntington/etnologia , Masculino , Pessoa de Meia-Idade , TurquiaRESUMO
Chronic administration of dopaminergic agonists to rats with unilateral 6-OH-dopamine (6-OHDA) lesions of nigrostriatal pathway produces behavioral sensitization to subsequent agonist challenges and may serve as a model for DOPA-induced dyskinesias. In order to understand striatal mechanisms behind this long-term behavioral change we examined striatal c-Fos and FosB immunoreactivity induced by apomorphine challenge (5 mg/kg, s.c.) after 3 days of withdrawal following a 2-week administration (5 mg/kg, b.i.d., s.c.) both in intact and 6-OHDA-lesioned animals. In intact rats, c-Fos induction by acute apomorphine exposure showed a striosomal pattern, whereas FosB immunopositivity was diffusely distributed. Following chronic administration, FosB induction turned to a clear striosome dominant pattern similar to c-Fos expression. In denervated striatum, expression of both proteins was profoundly augmented in a homogeneous pattern after a single dose of apomorphine. A distinct striosomal patterning appeared after chronic apomorphine administration in ventromedial part of the denervated striatum with a down-regulation in the matrix and relative enhancement in striosomes. These results suggest that compartmental reorganization of striatal neuronal activity may play a role in long-term behavioral changes induced by chronic dopaminergic treatments both under normal and dopamine-depleted conditions.
Assuntos
Apomorfina/farmacologia , Corpo Estriado/enzimologia , Agonistas de Dopamina/farmacologia , Dopamina/deficiência , Discinesia Induzida por Medicamentos/fisiopatologia , Proteínas Proto-Oncogênicas c-fos/biossíntese , Animais , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Calbindinas , Corpo Estriado/química , Corpo Estriado/efeitos dos fármacos , Denervação , Masculino , Proteínas do Tecido Nervoso/análise , Plasticidade Neuronal/fisiologia , Oxidopamina , Proteínas Proto-Oncogênicas c-fos/análise , Ratos , Ratos Wistar , Proteína G de Ligação ao Cálcio S100/análise , SimpatolíticosRESUMO
Autosomal recessive juvenile parkinsonism (AR-JP) is a distinct clinical and genetic entity characterized by selective degeneration of nigral neurons. Recently, the parkin gene responsible for AR-JP has been identified. To date, we found two different deletional mutations including single and multiple exonic deletions. In the present study, we identified two types of point mutations (Thr240Arg and Gln311Stop) involving exons 6 and 8 in the parkin gene of the AR-JP patients from two Turkish families. This is the first report on point mutations for the parkin gene. Furthermore, the Thr240Arg mutation was located on a consensus sequence for the site of phosphorylation by casein kinase II. Identification of its mutation provides an important clue as to the role of the Parkin protein in degeneration of the substantia nigra in the brain of AR-JP patients.
Assuntos
Ligases , Doença de Parkinson/genética , Mutação Puntual , Proteínas/genética , Ubiquitina-Proteína Ligases , Adolescente , Adulto , Sequência de Aminoácidos , Sequência de Bases , Códon de Terminação/genética , Consanguinidade , Primers do DNA/genética , Éxons , Feminino , Genes Recessivos , Humanos , Masculino , Linhagem , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Proteínas/química , TurquiaRESUMO
Parkinson disease (PD) is a common neurodegenerative condition associated with degeneration of dopaminergic neurons in the zona compacta of the substantia nigra. There is increasing evidence that genetic factors play a role in the etiology of PD, although genetic heterogeneity is likely. An autosomal dominant syndrome with many similarities to sporadic PD has been mapped to 4q21-22 in a large Italian pedigree and has been found to be due to mutation of the alpha-synuclein gene. However, this gene appears to account for only a minority of PD, and a susceptibility locus for autosomal dominant parkinsonism has recently been mapped, on 2p13. Autosomal recessive juvenile parkinsonism (JP), which shows marked clinical similarity to PD, maps to 6q25.2-q27. We found linkage to this region in a group of 15 families from four distinct ethnic backgrounds. A full genomic screen excluded other candidate regions. We have constructed a detailed genetic map of the linked region and have mapped the position of the manganese superoxide dismutase gene (SOD2). Recombination events restricted the JP locus to a 6.9-cM region and excluded SOD2. The apparent homozygosity for null alleles at D6S955 in one family suggested a deletion and finer localization of the JP locus.
Assuntos
Cromossomos Humanos Par 6/genética , Genes Recessivos/genética , Doença de Parkinson/etnologia , Doença de Parkinson/genética , Idade de Início , Alelos , Mapeamento Cromossômico , Consanguinidade , Feminino , Ligação Genética/genética , Humanos , Escore Lod , Masculino , Linhagem , Recombinação Genética/genética , Superóxido Dismutase/genéticaRESUMO
Chronic intermittent exposure to psychomotor stimulants induces in the striatum the expression of Fos-related proteins (Fras) that persist after the end of drug treatment. We carried out experiments to determine whether such Fras ("chronic Fras') require dopamine D1-class receptor function for their persistent expression in the striatum. We chronically administered cocaine to rats in a behavioral sensitization protocol and blocked D1-class receptors with SCH23390 before a final cocaine challenge. Western blotting and immunohistochemical analyses indicate that Fras persistently expressed in response to chronic treatment include proteins of two types: those that have become independent of D1-class dopamine receptor activation and those that remain dependent on D1-class receptors for their expression following drug challenge.
Assuntos
Cocaína/farmacologia , Inibidores da Captação de Dopamina/farmacologia , Neostriado/metabolismo , Proteínas Proto-Oncogênicas c-fos/biossíntese , Receptores de Dopamina D1/fisiologia , Animais , Benzazepinas/farmacologia , Western Blotting , Antagonistas de Dopamina/farmacologia , Imuno-Histoquímica , Masculino , Neostriado/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de Dopamina D1/antagonistas & inibidoresRESUMO
Repeated exposure to psychomotor stimulants produce long-term changes in behavior ranging from addiction to behavioral sensitization. Many of these behaviors depend on the nigrostriatal system of the basal ganglia. We show here that chronic cocaine exposure not only leads to time-varying alterations in the inducibility of bZIP transcription factors in individual striatal neurons, but also to long-lasting network changes in which ensembles of striatal neurons express these proteins. These network-level adaptations suggest that the behavioral sensitization induced by repeated psychomotor stimulant exposure may reflect an enduring functional reorganization of basal ganglia circuits.
Assuntos
Cocaína/farmacologia , Corpo Estriado/metabolismo , Rede Nervosa/fisiologia , Proteínas Proto-Oncogênicas c-fos/metabolismo , Proteínas Proto-Oncogênicas c-jun/metabolismo , Animais , Western Blotting , Núcleo Caudado/metabolismo , Cocaína/administração & dosagem , Dinorfinas/metabolismo , Imuno-Histoquímica , Interneurônios/fisiologia , Masculino , Neurônios/fisiologia , Fenótipo , Putamen/metabolismo , Ratos , Ratos Sprague-Dawley , Transmissão SinápticaRESUMO
In this study we investigated the physiologic mechanisms in primary brachial dystonia by analyzing the cutaneous EMG silent period during isometric contraction of the opponens pollicis muscle. Results from the affected and unaffected arms of 11 patients with dystonia were compared to 7 patients with Parkinson's disease and 16 age-matched normal individuals (controls). The silent period onset latency, degree of EMG suppression during the silent period, and EMG rebound at the end of the silent period did not differ significantly between patients with dystonia and any other group. The duration of the silent period (the S-X interval), however, was significantly prolonged in dystonia (p<0.005) and in Parkinson's disease (p<0.001) in both affected and unaffected arms compared with controls. These findings suggest that mechanisms responsible for the initiation of the cutaneously induced silent period and the subsequent suppression depth of EMG activity are not affected in brachial dystonia, but the abnormally prolonged S-X intervals may reflect dysfunctional basal ganglia timing influences over spinal circuitry common to both dystonia and Parkinson's disease.
Assuntos
Distonia/fisiopatologia , Doença de Parkinson/fisiopatologia , Pele/inervação , Adulto , Braço , Gânglios da Base/fisiologia , Gânglios da Base/fisiopatologia , Estimulação Elétrica , Eletromiografia , Seguimentos , Lateralidade Funcional , Humanos , Pessoa de Meia-Idade , Valores de Referência , Pele/fisiopatologia , Fenômenos Fisiológicos da Pele , Fatores de TempoRESUMO
We analyzed rest and postural hand tremors in a Parkinson's disease patient who developed and recovered from a right radial nerve palsy at the spiral groove, and found that, despite complete paralysis of all extensors below the elbow, tremor frequencies remained unchanged while tremor amplitudes actually increased. This provides compelling evidence for a central generation of parkinsonian tremor frequency that is not influenced by the effects of peripheral modulation. In addition, the increase in tremor amplitudes may be due to disinhibited flexor activity caused by normally operating spinal segmental mechanisms interacting with central tremor generators programmed to alternate between antagonist muscles. Peripheral treatment of tremors--with muscle paralysis or botulinum toxin, for example--therefore may not be effective in stopping tremor oscillations in Parkinson's disease and may even worsen tremor amplitudes if all antagonists of a tremoring joint are not treated equally.
Assuntos
Paralisia/fisiopatologia , Doença de Parkinson/fisiopatologia , Nervo Radial/fisiopatologia , Tremor/fisiopatologia , Idoso , Eletromiografia , Humanos , Masculino , Condução Nervosa , Paralisia/diagnóstico , Paralisia/etiologia , Doença de Parkinson/complicações , Doenças do Sistema Nervoso Periférico/diagnóstico , Doenças do Sistema Nervoso Periférico/etiologia , Doenças do Sistema Nervoso Periférico/fisiopatologia , PosturaRESUMO
We report a case of progressive spastic paraparesis in a 45-year-old man with total portal-systemic shunting, which developed spontaneously due to congenital hepatic fibrosis. Cellular functions of the liver, except for an elevated blood ammonia level, were within normal limits, as is usual in congenital hepatic fibrosis. This case shows that spastic paraparesis following portal-systemic shunting may occur without liver failure.
Assuntos
Circulação Hepática , Cirrose Hepática/complicações , Paraplegia/etiologia , Amônia/sangue , Humanos , Cirrose Hepática/congênito , Masculino , Pessoa de Meia-Idade , Espasticidade Muscular/etiologia , Espasticidade Muscular/fisiopatologia , Paraplegia/fisiopatologia , Sistema Porta/fisiopatologiaRESUMO
Botulism is a severe neuroparalytic disease caused by the neurotoxins of Clostridium botulinum which exert their effects on peripheral nerve junctions. Guillain-Barre syndrome, Myasthenia Gravis, acute Poliomyelitis and diphtheria must be considered in the differential diagnosis. In this study we have discussed two patients who were treated in our clinic, the differential diagnosis and the role of anti-Cholinesterase drugs in the treatment.